SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA concludes inspection at Baddi facility of Panacea Biotec’s arm

13 Oct 2023 Evaluate

United States Food and Drug Administration (USFDA) has concluded inspection at Panacea Biotec’s material wholly-owned subsidiary -- Panacea Biotec Pharma (PBPL) at Baddi, Himachal Pradesh. The said facility has been inspected between October 03, 2023 and October 12, 2023. 

At the end of inspection, PBPL was issued a ‘FDA Form 483’ with nine observations which are related to improvements in existing procedures and are addressable. PBPL will respond to the USFDA within the stipulated time and work closely with USFDA to close the said observations.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities.

Panacea Biotec Share Price

550.00 12.70 (2.36%)
15-Jun-2026 13:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1803.40
Dr. Reddys Lab 1281.00
Cipla 1382.00
Zydus Lifesciences 1089.45
Lupin 2274.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: